Title |
BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PRC1.1 from target genes
|
---|---|
Published in |
Blood Cancer Discovery, March 2022
|
DOI | 10.1158/2643-3230.bcd-21-0115 |
Pubmed ID | |
Authors |
Eva J Schaefer, Helen C Wang, Hannah Q Karp, Clifford A Meyer, Paloma Cejas, Micah D Gearhart, Emmalee R Adelman, Iman Fares, Annie Apffel, Klothilda Lim, Yingtian Xie, Christopher J Gibson, Monica Schenone, H Moses Murdock, Eunice S Wang, Lukasz P Gondek, Martin P Carroll, Rahul S Vedula, Eric S Winer, Jacqueline S Garcia, Richard M Stone, Marlise R Luskin, Steven A Carr, Henry W Long, Vivian J Bardwell, Maria E Figueroa, R Coleman Lindsley |
X Demographics
The data shown below were collected from the profiles of 35 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 19 | 54% |
Germany | 1 | 3% |
Spain | 1 | 3% |
Unknown | 14 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 18 | 51% |
Members of the public | 12 | 34% |
Practitioners (doctors, other healthcare professionals) | 3 | 9% |
Science communicators (journalists, bloggers, editors) | 2 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 34 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 21% |
Researcher | 4 | 12% |
Student > Postgraduate | 3 | 9% |
Unspecified | 2 | 6% |
Student > Doctoral Student | 1 | 3% |
Other | 5 | 15% |
Unknown | 12 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 11 | 32% |
Medicine and Dentistry | 5 | 15% |
Agricultural and Biological Sciences | 2 | 6% |
Unspecified | 2 | 6% |
Neuroscience | 1 | 3% |
Other | 1 | 3% |
Unknown | 12 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 December 2023.
All research outputs
#1,798,014
of 25,837,817 outputs
Outputs from Blood Cancer Discovery
#73
of 212 outputs
Outputs of similar age
#42,960
of 450,767 outputs
Outputs of similar age from Blood Cancer Discovery
#6
of 18 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 212 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.6. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,767 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.